OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Notice of Results
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance testing, announces t hat it will release its financial results for the year ended 31 March 2020 on Tuesday 14 July 2020.
Omega will be hosting a live online presentation open to all investors on Wednesday 15 July at 4.30pm, delivered by Colin King, CEO. The Company is committed to providing an opportunity for all existing and potential investors to hear directly from management on its results whilst additionally providing an update on the business and current trading.
The presentation will be hosted through the digital platform Investor Meet Company. Investors can sign up to Investor Meet Company for free and add to meet Omega Diagnostics plc via the following link:
https://investormeetcompany.com/omega-diagnostics-group-plc/register-investor .
For those investors who have already registered and added to meet the Company, they will automatically be invited.
Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the "Ask a Question" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards.
Contacts:
Omega Diagnostics Group PLC |
Tel: 01259 763 030 |
Bill Rhodes, Interim Non-Executive Chairman Colin King, Chief Executive |
|
Kieron Harbinson, Group Finance Director |
|
|
|
finnCap Ltd |
Tel: 020 7220 0500 |
Geoff Nash/Hannah Boros (Corporate Finance) |
|
Camille Gochez (ECM) |
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or omega@walbrookpr.com |
Paul McManus |
Mob: 07980 541 893 |
Lianne Cawthorne |
Mob: 07584 391 303 |